Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Submitted by
admin
on June 25, 2013 - 12:20pm
Source:
Seeking Alpha
News Tags:
Cempra
superbugs
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Celldex
Trius Therapeutics
Headline:
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Do Not Allow Advertisers to Use My Personal information
